BlueSkeye AI is solving a massive global health problem with ethical AI.

BlueSkeye AI is featured in TechEntrepreneur Podcast series. Ton Dobbe, author of the Remarkable Effect, which defines the traits of successful software businesses, interviewed our CEO and co-founder of BlueSkeye AI, Michel Valstar.

Ton’s podcast series focuses on software technologies and their founders who have something remarkable to talk about. We were delighted to talk about the impact that BlueSkeye AI is having.

“Roughly half the people on this planet will give birth to a child, and 10-20% of those women will suffer, unfortunately, from poor mental health…. Even if we could only help 10% of these people, this would be a massive contribution to humanity”. (Michel Valstar, CEO and co-founder BlueSkeye AI)

In this podcast you can hear how BlueSkeye AI is tackling big social problems and contributing to improving mental health. Michel talks candidly about BlueSkeye AI’s commitment to creating value from using AI technology for individuals and health populations, specifically in the context of the early detection of perinatal mental health issues or problems ahead of the exciting launch of our new Health and Wellbeing App.

Ton and Michel talked about the distinctive way in which BlueSkeye AI technology and its products have been architected ethically to recognise individuals’ expressive behaviour to assist with the objective early detection of mental health states.

Michel talks openly about BlueSkeye AI’s vision to develop technology that solves problems, contributes to humanity and generates value, all whilst being designed with users in mind to ensure maximum engagement and adoption at a time when the market is ready.

You can listen in full and read more about the interview and the key lessons learnt from Ton Dobbe at

If you would like to sign up to the early access of Avocado please fill out this form and we will be in touch with you.


You might also like

BlueSkeye AI shortlisted as a finalist for the Medilink Midlands Business Awards 2022
We are excited to announce that BlueSkeye AI has been shortlisted as a finalist for the Medilink Midlands Business Awards 2022.   BlueSkeye AI have been selected as a finalist for the 2022 Medilink Innovation Award category.  The winners of the Awards will be announced at the Award Ceremony held in Nottingham on 27 January…
View Article
Read more
Steve Cliffe joins BlueSkeye AI as it scales the development of its technology and customer portfolio.
BlueSkeye AI appoints Steve Cliffe to its board of directors. BlueSkeye has deepened the deep tech expertise on its board by appointing former CEO of Ultraleap, Steve Cliffe as a Non-Executive Director and special advisor.  Steve Cliffe joins BlueSkeye as the company scales and advances its ethical AI technology, partnerships and customer portfolio.  Rebecca Ganz,…
View Article
Read more